AML1 / RUNX1 Antibody Blocking Peptide

AML1 / RUNX1

RUNX1 | AMLCR1 | Aml1 oncogene | AML1 | AML1-EVI-1 | CBF-alpha-2 | CBFA2 | Acute myeloid leukemia 1 | EVI-1 | PEBP2A2 | PEA2-alpha B | AML1-EVI-1 fusion protein | Oncogene AML-1 | PEBP2-alpha B | PEBP2aB

Lyophilized

Add distilled water/PBS to give a target peptide concentration of 1-5mg/mL, and sonicate. To any insoluble peptide add pure acetic acid to bring the concentration of acetic acid to 10% (v/v), and sonicate. If the peptide remains insoluble, add acetonitrile to 20% (v/v), and sonicate. If the peptide again remains insoluble, lyophilize the peptide and add neat DMF dropwise until the peptide dissolves. Dilute this solution slowly with water to give approximately 10% (v/v) DMF. If the peptide precipitates at any stage during this step, stop adding water and add a little more DMF until the peptide redissolves.

Greater than 85%

Store at -20°C for up to 1 year.

LS-E40532 is the immunizing peptide used to generate LS-C358858. Useful for pre-absorption and neutralization of the antibody's antigen binding site.

For research use only. Intended for use by laboratory professionals.